Codexis - CDXS Market Valuation

This price chart for Codexis, Inc. (CDXS), which has a market capitalization of 0.11, illustrates the price action of the bioengineered protein developer. The business is exposed to risks from trade conflicts and raw material supply chain disruptions. Codexis, Inc. (CDXS) relies on partnerships with the food and medical sectors to create custom enzymes, while multi-year licensing agreements with pharmaceutical behemoths ensure a stable cash flow.

CDXS Codexis: Market Capitalization in the range 07/04/2022 - 11/11/2026

codexis.com - analytical breakdowns and key metrics (CDXS)

- current price and projected stock value:

Stock Price Codexis|CDXS - Broker Consensus Forecast

- issuer market value details:

Market Valuation CDXS|CDXS - Business Value

- business book valuation details:

Net Assets per Single Share Codexis, Inc.|CDXS - Book Valuation of Business|Market Capitalization to Book Value Ratio codexis.com|CDXS - Total Business Assets

- company total debt and liquidity indicators:

- business earnings and investment ratios data:

CDXS - Company Profit|Projected Future Earnings Codexis, Inc.|CDXS - Market Cap to Earnings|Projected Price to Earnings Codexis|CDXS - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple CDXS|CDXS - Operating income before deduction of amortization|Earnings per share for the last twelve months Codexis, Inc.|CDXS - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months codexis.com|CDXS - Earnings per share increase in current year|Earnings growth forecast for next year Codexis, Inc.

Fundamental company analysis:Codexis Bio CDXS

The market capitalization of Codexis, Inc. (CDXS) reflects the market valuation of its unique DNA technologies and patent protection. This metric is calculated as the product of the current share price and the total number of outstanding securities. By analyzing the company's market value on the exchange, an investor sees the consensus regarding the cost of its integration into pharmaceutical production. High customer switching costs support the stability of this metric. This chart's price action allows for the distinction between fundamental growth and temporary speculation.

Competitors of Codexis, Inc. (CDXS)